Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5795235-(2-hydroxyl-1-methyl)-ethyl-4,5-dihydrofurano(2,3-h)(4'-hydroxyl-3',5'-dimethoxy)isoflavoneMeSH

  from Psoralea corylifolia; structure in first source

• C5734385-(2-phenoxyacetamide)-10,15,20-tris(triphenylamine)porphyrinato zinc(II)MeSH

  structure in first source

• C5827515-(2-phenylethyl)-3-hydroxyphenol-1-O-beta-D-glucopyranosideMeSH

  from the leaves of Litsea coreana; structure in first source

• C5605835-(3',5'-dichlorobiphenyl-4-yl)-2,3-dihydroxy-4-(2-methoxyacetamido)pentanoic acidMeSH

  inhibits Cdc24; structure in first source

• C5832445-(3,4-methylenedioxyphenyl)-4-ethyl-2,4-pentadienoic acid piperidideMeSH

  a Staphylococcus aureus NorA efflux pump inhibitor that enhances drug bioavailability; structure in first source

• C5688465-(3,6-diazabicyclo(3.2.0)heptan-6-yl)nicotinonitrileMeSH

  an alpha4beta2 neuronal nicotinic receptor agonist with antinociceptive activity; structure in first source

• C5705395-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedioneMeSH

  a PPARgamma modulator; structure in first source

• C5685115-(3-(2-(2-hydroxy-1-(hydroxymethyl)ethyl)-5-methyl-1,2,3,4-tetrahydro-6-isoquinolinyl)-1,2,4-oxadiazol-5-yl)-2-((1-methylethyl)oxy)benzonitrileMeSH

  an S1P1 and S1P5 receptor agonist; structure in first source

• C5685165-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamideMeSH

  structure in first source

• C5603385-(3-(4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-1,4-diazepan-1-yl)propyl)-5,11-dihydrodibenzo(b,e)(1,4)oxazepine-7-carboxylic acidMeSH

  structure in first source

• C5718455-(3-biphenyl-4-yl-5-ethyl-4H-1,2,4-triazol-4-yl)isoquinolineMeSH

  structure in first source

• C5823025-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo(a)phenanthridin-4(1H)-oneMeSH

  structure in first source

• C5870485-(3-bromophenyl)-1,3-dihydro-2H-benzofuro(3,2-e)-1,4-diazepin-2-oneMeSH

  a P2X4 receptor antagonist; structure in first source

• C5712845-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidineMeSH

  structure in first source

• C5683655-(3-ethynylphenylamino)pyrimido(4,5-c)quinoline-8-carboxylic acidMeSH

  structure in first source

• C5865245-(3-fluoropropyloxy)tryptophanMeSH

  a PET imaging agent; structure in first source

• C5736215-(3-hydroxyphenyl)-2-phenethyl-2-azabicyclo(3.3.1)nonan-4-olMeSH

  structure in first source

• C5809325-(3-methyl-2-butenyloxy)-6,7-methylenedioxycoumarinMeSH

  has antineoplastic activity; structure in first source

• C5763975-(3-methylphenoxy)-2(1H)-pyrimidinoneMeSH

  a Lyn kinase activator and antidiabetic agent; structure in first source

• C5779505-(4-(1-(4-(difluoromethoxy)benzoyl)piperidin-4-yloxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trioneMeSH

  an anti-obesity agent; structure in first source

• C5709175-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2-pyridin-2-yl-2H-pyridazin-3-oneMeSH

  a nootropic agent; structure in first source

• C5698265-(4-(5-carboxy-1-butoxy)phenyl)-10,15,20-tris(4-N-methyl)pyridiniumylporphyrinMeSH

  a photosensitizing agent

• C5881365-(4-(benzoxazol-2-yl-5-acetic acid)phenylazo)-2-hydroxybenzoic acidMeSH

  structure in first source

• C5752745-(4-(benzyloxy)-3-chlorobenzylidene)dihydro-2-thioxopyrimidine-4,6(1H,5H)-dioneMeSH

  a PPARgamma scaffold; structure in first source

• C5600835-(4-(cyclopentylmethoxy)benzylidene)thiazolidine-2,4-dioneMeSH

  an algicide; structure in first source

• C5881325-(4-N,N-diacetoxylphenyl)-10,15,20-tetraphenylporphyrinMeSH
• C5747685-(4-acetyl(1,4)diazepan-1-yl)pentanoic acid (5-(4-methoxyphenyl)-1H-pyrazol-3-yl) amideMeSH

  an alpha7 nicotinic acetylcholine receptor agonist; structure in first source

• C5711935-(4-bromobenzyloxy)-2-(2-(5-methoxyindolyl)ethyl-1-carbonyl)-4H-chromen-4-oneMeSH

  inhibits breast cancer resistance protein; structure in first source

• C5873445-(4-bromophenyl)-1,3,4-thiadiazol-2-amineMeSH

  structure in first source

• C5709265-(4-chloro-phenyl)-1-phenyl-6-(4-pyrazin-2-yl-phenyl)-1,5-dihydro-pyrazolo(3,4-d)pyrimidin-4-oneMeSH

  a brain-penetrating CB1 receptor inverse agonist

• C5812475-(4-chlorobenzylidene)-3-(4-methylbenzyl)thiazolidine-2,4-dioneMeSH

  an anti-atherosclerotic agent; structure in first source

• C5702905-(4-chlorophenyl)-3-methyl-2-(2-(((1-methylethyl)amino)methyl)-1-pyrrolidinyl)-6-(4-pyridinyl)-4(3H)-pyrimidinoneMeSH

  structure in first source

• C5752655-(4-chlorophenyl)-4-(3-(4-(4-(4-((4-(dimethylamino)-1-(phenylthio)-butan-2-yl)amino)-3-nitrophenylsulfonamido)phenyl)piperazin-1-yl)phenyl)-1-isopropyl-2-methyl-1H-pyrrole-3-carboxylic acidMeSH

  an antineoplastic agent that inhibits both Bcl-2 and Bcl-xL; structure in first source

• C5752645-(4-chlorophenyl)-4-(3-(4-(4-(4-((4-(dimethylamino)-1-(phenylthio)butan-2-yl)amino)-3-nitrophenylsulfonamido)phenyl)piperazin-1-yl)phenyl)-1-ethyl-2-methyl-1H-pyrrole-3-carboxylic acidMeSH

  an antineoplastic agent that inhibits both Bcl-2 and Bcl-xL; structure in first source

• C5833285-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxothiazolidine-3 carboxamideMeSH

  hexythiazox is the (trans)-isomer

• C5714475-(4-cyano-3-methylphenyl)-2-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)nicotinitrileMeSH

  a GPR119 agonist; structure in first source

• C5691955-(4-hydroxy-3,5-dimethylbenzylidene)thiazolidine-2,4-dioneMeSH

  an anti-angiogenic agent with free radical scavenger activity; structure in first source

• C5735575-(4-hydroxy-3-trifluoromethylbenzylidene)-3-(4,4,4-trifluoro-2-methyl-2-(2,2,2-trifluoroethyl)butyl)thiazolidine-2,4-dioneMeSH

  has antineoplastic activity; structure in first source

• C5622175-(4-methoxycarbonylphenyl)-10,15,20-triphenyl-21H,23H-porphinMeSH

  structure in first source

• C5695555-(4-trifluorophenyl)-10,15,20-tris(4-N,N,N-trimethylammoniumphenyl)porphyrinMeSH

  a photosensitizing agent; structure in first source

• C5755335-(5-((3,5-dimethylpiperazin-1-yl)sulfonyl)-2-ethoxyphenyl)-l-methyl-7-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-3-propyl-1H-pyrazolo(4,3-d)pyrimidineMeSH

  sildenafil analog; structure in first source

• C5789815-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dioneMeSH

  activates death receptor 5 (DR5); structure in first source

• C5784905-(5-(2-fluoroethoxy)benzo(d)oxazol-2-yl)-N-methylpyridin-2-amineMeSH

  structure in first source

• C5765145-(5-(6-((11)C)methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)pyridin-2-yl)-1H-indolMeSH

  structure in first source

• C5760555-(5-bromo-2-methoxybenzylidene)-3-(4-methyl-benzyl)thiazolidine-2,4-dioneMeSH

  structure in first source

• C5810735-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazoleMeSH

  structure in first source

• C5747675-(6,7-dimethoxycinnolin-4-yl)-N-isopropyl-3-methylpyridin-2-amineMeSH

  a phosphodiesterase 10A tracer; structure in first source

• C5833685-(6-(5-methylhexahydropyrrolo(3,4-c)pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indoleMeSH

  a PET imaging agent for alpha7-nicotinic acetylcholine receptors; structure in first source

• C5864205-(6-amino-2-azido-9H-purin-9-yl)-3-((4-ethynylphenyl)(hydroxy)methyl)cyclopent-3-ene-1,2-diolMeSH

  structure in first source

• C5719325-(6-dimethylamino-2-methyl-3-oxo-2,3-dihydro-benzofuran-2-yl)-4-methyl-penta-2,4-dienoic acid hydroxamideMeSH